Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Khasraw

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Journal for Immunotherapy of Cancer|July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumorsAaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
Nature Reviews. Clinical Oncology|December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directionsAhmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Journal for Immunotherapy of Cancer|February 20, 2021
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumorsJason J Luke, Fabrice Barlesi, Ki Chung, et al.
Oncoimmunology|July 30, 2016
Prioritization schema for immunotherapy clinical trials in glioblastomaTiffany R Hodges, Sherise D Ferguson, Hillary G Caruso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM StudyEva Segelov, Subotheni Thavaneswaran, Paul M Waring, et al.
Nature Cancer|August 3, 2023
CD8<sup>+</sup> T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axisEmily C Lerner, Karolina I Woroniecka, Vincent M D'Anniballe, et al.
Cancer Cell|April 29, 2022
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibitionJustin T Low, Vidyalakshmi Chandramohan, Michelle L Bowie, et al.
Neuro-Oncology|April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experienceEudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaKirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in GliomasShiyou Wei, Delong Yin, Shengnan Yu, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Journal for Immunotherapy of Cancer|July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumorsAaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
Nature Reviews. Clinical Oncology|December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directionsAhmad Ozair, Hannah Wilding, Debarati Bhanja, et al.
Journal for Immunotherapy of Cancer|February 20, 2021
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumorsJason J Luke, Fabrice Barlesi, Ki Chung, et al.
Oncoimmunology|July 30, 2016
Prioritization schema for immunotherapy clinical trials in glioblastomaTiffany R Hodges, Sherise D Ferguson, Hillary G Caruso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM StudyEva Segelov, Subotheni Thavaneswaran, Paul M Waring, et al.
Nature Cancer|August 3, 2023
CD8<sup>+</sup> T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axisEmily C Lerner, Karolina I Woroniecka, Vincent M D'Anniballe, et al.
Cancer Cell|April 29, 2022
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibitionJustin T Low, Vidyalakshmi Chandramohan, Michelle L Bowie, et al.
Neuro-Oncology|April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experienceEudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaKirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in GliomasShiyou Wei, Delong Yin, Shengnan Yu, et al.
Pageof 18